| Original language | English |
|---|---|
| Pages (from-to) | e3 |
| Journal | American Heart Journal |
| Volume | 163 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2012 |
| Externally published | Yes |
Reply to the letter by Chatterjee et al "bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial"
Jeffery S. Berger, Deepak L. Bhatt
Research output: Contribution to journal › Letter › peer-review